Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Acadia Healthcare Company (ACHC) over the last 11 years, with Q3 2025 value amounting to $2.1 million.

  • Acadia Healthcare Company's Income from Non-Controlling Interests fell 3600.12% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 1500.1%. This contributed to the annual value of $8.9 million for FY2024, which is 4771.89% up from last year.
  • As of Q3 2025, Acadia Healthcare Company's Income from Non-Controlling Interests stood at $2.1 million, which was down 3600.12% from $7.8 million recorded in Q2 2025.
  • Acadia Healthcare Company's Income from Non-Controlling Interests' 5-year high stood at $7.8 million during Q2 2025, with a 5-year trough of $543000.0 in Q1 2023.
  • Its 5-year average for Income from Non-Controlling Interests is $2.0 million, with a median of $1.9 million in 2022.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first surged by 33959.48% in 2024, then crashed by 7109.34% in 2025.
  • Acadia Healthcare Company's Income from Non-Controlling Interests (Quarter) stood at $1.2 million in 2021, then surged by 62.85% to $2.0 million in 2022, then rose by 0.35% to $2.0 million in 2023, then crashed by 54.93% to $914000.0 in 2024, then skyrocketed by 126.59% to $2.1 million in 2025.
  • Its Income from Non-Controlling Interests was $2.1 million in Q3 2025, compared to $7.8 million in Q2 2025 and $690000.0 in Q1 2025.